Melbourne, FL and Houston, TX – September 30, 2023 – Alertgy, a pioneering force in diabetes technology, is pleased to announce the appointment of Ruba Sarris Sawaya as a Senior Advisor for Quality, Regulatory & Clinical Affairs.
With a remarkable career in medtech, including roles as the Chief Scientific Officer at TYBR Health, Executive Vice President of Clinical Affairs at Don Joy Orthopedics, Director of GCORE (Government Affairs, Clinical Affairs & Center for Outcomes Research, Reimbursement & Evaluation) at Orthofix, and multiple senior leadership positions within Medtronic’s Restorative Therapies Group, Mrs. Sawaya brings a wealth of corporate strategy expertise and a track record of high-impact regulatory, clinical, and reimbursement initiatives enabling successful device commercialization and market access. Her vast experience and proven leadership will be instrumental in advancing Alertgy’s diabetes device technology and ensuring the highest standards of quality, regulatory compliance, and clinical excellence.
“We are excited to welcome Ruba and look forward to working with her on the next stage of Alertgy’s growth. We feel that she will be an indispensable asset as we continue to chart our regulatory path.” John Hubert Interim CEO/COO.
About Alertgy: Alertgy stands as a trailblazer in the realm of Non-Invasive continuous blood glucose monitoring (CGM) technologies. At the heart of its mission is development of DeepGluco™, an integrated continuous glucose monitor enriched with a patented sensor and powerful proprietary AI algorithms that’s poised to redefine diabetes management by merging cutting edge technology with a user-centric design.
For more information please contact:
John Hubert
Interim CEO/COO john.hubert@alertgy.com